Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection by Müller, Ivo et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
Malaria Journal
Open Access Research
Three different Plasmodium species show similar patterns of 
clinical tolerance of malaria infection
Ivo Müller1,2, Blaise Genton1, Lawrence Rare2, Benson Kiniboro2, 
Will Kastens3, Peter Zimmerman3, James Kazura3, Michael Alpers2 and 
Thomas A Smith*1
Address: 1Department of Public Health & Epidemiology, Swiss Tropical Institute, Socinstrasse 57, Postfach CH-4002, Basel, Switzerland, 2Papua 
New Guinea Institute of Medical Research, PO Box 60, Goroka, Papua New Guinea and 3Center for Global Health & Diseases, Case Western 
Reserve University, Cleveland, OH, USA
Email: Ivo Müller - ivomueller@fastmail.fm; Blaise Genton - Blaise.Genton@unibas.ch; Lawrence Rare - pngimr_lrare@datec.net.pg; 
Benson Kiniboro - pngimr_en@datec.net.pg; Will Kastens - wkastens@datec.net.pg; Peter Zimmerman - Peter.Zimmerman@case.edu; 
James Kazura - James.Kazura@case.edu; Michael Alpers - M.Alpers@curtin.edu.au; Thomas A Smith* - Thomas-A.Smith@unibas.ch
* Corresponding author    
Abstract
Background:  In areas where malaria endemicity is high, many people harbour blood stage
parasites without acute febrile illness, complicating the estimation of disease burden from infection
data. For Plasmodium falciparum the density of parasitaemia that can be tolerated is low in the
youngest children, but reaches a maximum in the age groups at highest risk of infection. There is
little data on the age dependence of tolerance in other species of human malaria.
Methods: Parasite densities measured in 24,386 presumptive malaria cases at two local health
centres in the Wosera area of Papua New Guinea were compared with the distributions of parasite
densities recorded in community surveys in the same area. We then analyse the proportions of
cases attributable to each of Plasmodium falciparum, P. vivax, and P. malariae as functions of parasite
density and age using a latent class model. These attributable fractions are then used to compute
the incidence of attributable disease.
Results: Overall 33.3%, 6.1%, and 0.1% of the presumptive cases were attributable to P. falciparum,
P. vivax, and P. malariae respectively. The incidence of attributable disease and parasite density
broadly follow similar age patterns. The logarithm of the incidence of acute illness is approximately
proportion to the logarithm of the parasite density for all three malaria species, with little age
variation in the relationship for P. vivax or P. malariae. P. falciparum shows more age variation in
disease incidence at given levels of parasitaemia than the other species.
Conclusion: The similarities between Plasmodium species in the relationships between parasite
density and risk of attributable disease are compatible with the hypothesis that pan-specific
mechanisms may regulate tolerance to different human Plasmodia. A straightforward mathematical
expression might be used to project disease burden from parasite density distributions assessed in
community-based parasitological surveys.
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Background
Residents of malaria endemic areas frequently harbour
asexual blood stage parasites without developing symp-
toms or signs of acute febrile illness, implying that some
degree of clinical tolerance to parasitaemia is acquired
through repeated exposure to and experience with chronic
blood stage infection. Epidemiological studies of this phe-
nomenon have focused mainly on Plasmodium falciparum,
the dominant malaria species world wide, and attempted
to quantify this complex clinical phenotype at a popula-
tion level by estimating the peripheral parasite density at
which body temperature exceeds a specific level or cut off
value, i.e. the pyrogenic threshold [1]) or the probability
of acute febrile illness as a function of parasite density [2-
4]. In contrast, similar analyses of clinical tolerance to
other major malaria species that infect humans, Plasmo-
dium vivax, Plasmodium malariae and Plasmodium ovale, are
limited to one study of P. vivax from Punjab [5] and
another of P. ovale from Senegal [6].
Understanding the differences in clinical tolerance to par-
asitaemia among various malaria species may be impor-
tant in areas of the world where P. vivax and P. falciparum
are co-endemic such as in Asia, the Pacific and South
America. Anti-malarial drug resistance or deployment of
vaccines that preferentially affects one species may alter
innate and adaptive immunity and clinical tolerance to
the other.
In highly endemic areas for P. falciparum, the fever thresh-
old expressed in terms of the density of parasitaemia in
peripheral blood at which a given body temperature is
exceeded declines progressively after the age of one year
[1,2,7]. Thus, children with high parasite densities tend to
be asymptomatic compared with adults or adolescents
with similar levels of peripheral parasitaemia. Neverthe-
less adults have a lower incidence of clinical malaria
attacks than children. because P. falciparum density is on
average controlled at a lower level in adults than children
This is consistent with the idea that tolerance is the conse-
quence of an immunological response with little memory,
stimulated by toxins released during schizogony, and sev-
eral possible mediators of tolerance have been proposed
with this in mind, notably the anti-inflammatory mole-
cule nitric oxide (NO) [8] and antibodies to GPI [1]. How-
ever recent studies in Papua New Guinea suggest that
cytokine responses to GPI can better account for both
immunological and epidemiological patterns [9].
Variations in tolerance are only one possible explanation
for differences in the operating characteristics of diagnos-
tic thresholds of peripheral parasitaemia in P. falciparum.
Changes in pyrogenic threshold could also be explained
in terms of differences in the ratio of circulating to seques-
tered parasites. Pyrogens or putative malaria toxins are
released when sequestered P. falciparum-infected erythro-
cytes burst during schizogony. Hence pyrogen concentra-
tions may reflect more directly the density of sequestered
parasites than that of trophozoites in the peripheral circu-
lation. At present, approaches for assessing the number of
sequestered P. falciparum parasites in the living human
host remain controversial [10,11], and there is no means
of reliably quantifying circulating toxix(s) until their
molecular nature is better understood. In contrast, the rate
of schizogony and level of malaria toxin release should be
approximately proportional to the peripheral blood para-
site density in P. vivax and P. malariae infection since these
species are not thought to sequester in deep vascular beds.
In population based studies, it is possible to estimate the
apparent degree of clinical tolerance relative to the proba-
bility of an individual experiencing a given peripheral
density. This approach may be a better way of assessing
tolerance than using specific diagnostic cut-off values
since the latter depends on the extent of incidental parasi-
taemia in a population as well as the pathogenic effect of
a given parasite density. We have carried out an analysis of
the relationships between the incidence of acute illness
attributable to P. vivax and P. malariae and the densities of
circulating parasites in an area of Papua New Guinea
where these two malaria species as well as P. falciparum are
highly endemic, over the period 1991–2003. The results
for P. vivax and P. malariae are compared with those for P.
falciparum, with consideration of the age dependence of
apparent tolerance for each malaria species and implica-
tions for models of malaria pathogenesis and disease bur-
den.
Methods
Study area and population
The study involved residents of 29 villages in the Wosera
area of East Sepik Province, Papua New Guinea. The aver-
age population over the study period was 11,627 persons.
Transmission is perennial with estimated inoculation
rates for P. falciparum, P. vivax and P. malariae averaging
35, 12, and 10 infectious bites per annum respectively
during the period of 1990–1992 [12].
A detailed description of malaria species infection rates
has been presented elsewhere [13,14]. Malariometric sur-
veys showed an overall decrease in overall Plasmodium
spp. prevalence rate from 60% in the early 1990s to 35%
by 2002. The reduction was from 38% to 22% for P. falci-
parum, 20% to 10% for P. vivax, and 16% to 4% for P.
malariae  [15]. This was probably related to gradual
increase in the use of insecticide-treated nets and change
in the national policy for anti-malarial treatment of
asymptomatic parasitaemia.Malaria Journal 2009, 8:158 http://www.malariajournal.com/content/8/1/158
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Case detection and investigation
The area is serviced by two local health centers located in
the villages of Kunjingini and Kaugia and the health
records of 24,386 presumptive malaria cases diagnosed at
these health centres during the study period. A presump-
tive case of malaria was defined as an outpatient with a
clinical diagnosis of malaria made by nurses staffing one
or other of these health centers. The diagnostic procedures
used followed the guidelines of the Papua New Guinea
Department of Health [16], and usually the diagnosis of
malaria was based on a history of fever without obvious
symptoms or signs of another disease [17]. Malaria was
the most frequent clinical diagnosis, followed by acute
respiratory infections and skin conditions [18].
Treatment procedures at the health centres also followed
the guidelines of the PNG Department of Health, which
recommended malaria treatment for all patients with
fever [16] with various changes in drug regimens during
the course of the study. All individuals with a presumptive
diagnosis of malaria had a blood film prepared to detect
malaria parasites.
A research nurse from the Papua New Guinea Institute of
Medical Research attended the outpatient clinics from 8
AM to 2 PM Monday through Friday and further investi-
gated all presumptive malaria cases reporting on those
days. After recording demographic information a perti-
nent history of illness was taken, e.g. duration of self-
appraised fever before reporting to the health center, a
standardized physical examination that included auscul-
tation of the chest and heart and abdominal palpation to
detect pain and enlargement of the spleen and liver was
performed followed by a finger prick blood sample col-
lected for microscopic detection of malaria by microscopy
and haemoglobin measurement (for details see [14,19]).
Cross-sectional surveys
Blood films from control subjects were collected in three
series of cross-sectional community surveys conducted in
1991/92 [13], 1998/99 [20] and 2001–03[15]. Only par-
asitological data from participants, who had no signs of
concurrent febrile illness and did not report illness during
the previous week were included. Blood film results from
31,455 participants were included in the analysis of the
controls.
Laboratory examination for malaria
Blood films were stained with 4% Giemsa; 100 micro-
scopic thick film fields were inspected before a slide was
being declared malaria-negative. For malaria-positive
blood films, parasite species were identified and densities
recorded as the number of parasites per 200 WBC. This
procedure was followed for each species. Densities were
converted to asexual parasites per μl of blood assuming
8000 WBC per μl. Routine quality control procedures
were performed [19]. Briefly, a 10% random sample of
slides and all those that had a density between one and
five asexual stage P. falciparum, P. vivax, P. malariae, or P.
ovale were re-read by a supervisor microscopist blinded to
the first reading. When the results on a batch of ~1,000
slides did not reach 75% agreement on positivity/negativ-
ity, species and density (including a margin of error that
increased with increasing density), the entire batch was re-
read and the same quality control applied again. Clinical
cases observed to be infected with more than one malaria
species were included only in the analyses of the domi-
nant species on the assumption that this was the most
likely to be the cause of the febrile illness.
Model for dependence of fever risk on parasite density
Cases corresponded to the presumptive malaria cases
detected by passive case detection of persons reporting to
local health centers plus a positive blood smear for
malaria. Control slides were collected from asymptomatic
individuals who donated during the cross-sectional sur-
veys. Our analysis resolved the distribution of parasite
densities in the presumptive malaria cases into two com-
ponents, corresponding to non-malaria illness and to epi-
sodes of clinical malaria.
The parasite densities of controls and cases were divided
into K ordered categories, k = 1, 2,.., K. We define n(k) to
be the number of presumptive malaria cases in parasite
density category k, and θs(k) to be the corresponding pro-
portion of all presumptive cases (Figure 1a). We define
θc(k) to be the proportion of control individuals in cate-
gory k (Figure 1b), and θm(k) to be the proportion of true
clinical malaria patients in the same category (Figure 1e).
θs(k) then arises as the mixture:
on the assumption that θc(k) also gives the distribution of
parasite densities in those presumptive cases that in reality
have non-malaria aetiology, and where Λ is the overall
proportion of cases whose illness is attributable to malaria
(the malaria-attributable fraction). A latent class model
was then fitted to the counts of cases and controls, using
the simulation-based Bayesian approach described in
detail previously[21], implemented in WinBUGS [22]
(code available at http://www.sti.ch/en/research/pub
altand-epidemiology/biostatistics/down loads.html).,
This provided estimates both of Λ and of λ (k), the mixing
proportion among the cases in each category k, where:
θθ θ sm c kk k () () ( ) () , =+ − ΛΛ 1 (1)
λ
θ
θ
()
()
()
, k m k
s k
=
Λ
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subject to the constraint that λ (k) is an increasing func-
tion of k [21]. These were then used to obtain estimates of
the number of malaria attributable cases in the category, λ
(k)n(k) (Figure 1c). The effects of age and Plasmodium spe-
cies were summarized by carrying out this analysis sepa-
rately for each age group of host and each of the three
malaria species considered.
Operating characteristics of case definitions
In epidemiological studies, clinical malaria is frequently
defined to correspond to all febrile episodes with parasite
densities exceeding a given cut-off value (e.g. [23-25]).
Following [26], the sensitivity of the cut-off that corre-
sponds to the lower bound of category C, is given by:
the positive predictive value by:
and the specificity is:
Pr( | ) ( ) kC k m
kC
K
≥=
= ∑ malaria episode θ (3)
Pr( | )
() ()
()
malaria episode kC
k s k
kC
K
s k
kC
K ≥= =
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0
(5)
Age-, species-, and parasite density-specific data and results Figure 1
Age-, species-, and parasite density-specific data and results. A: numbers of cases included in the analysis. B: numbers 
of controls included in the analysis. C: estimated numbers of malaria attributable cases. D: proportions of all cases. E: propor-
tions of malaria specific cases.
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Calculation of clinical malaria incidence
To compare malaria incidence between species and age
groups at different parasite densities we estimated the
approximate person-time at risk in each category, using
population sizes and age distributions from the Wosera
demographic surveillance system [27] and the distribu-
tions of parasite densities in the control samples. The
overall incidence of clinical malaria in each parasite den-
sity class was then computed by dividing the total number
of episodes by this overall person-time-at-risk. The esti-
mated incidence was then re-scaled to give an adjusted
overall incidence of presumptive malaria attending health
facilities equal to our previously published estimate of
0.49 episodes per person-year [18] for outpatient visits to
Kunjingini.
Results
Age patterns of infection
27.3% of blood smears from control subjects were posi-
tive by blood slide for P. falciparum, 14.1% for P. vivax,
7.0% for P. malariae, and nil for P. ovale. 5.5% of slides
were positive for more than one species. Infection reached
a peak prevalence in children between four and six years
of age (P. vivax) and between seven and nine years of age
(P. falciparum) (Figure 2)) [12,13,15]. Plasmodium malar-
iae infection is much less frequent than either of the other
two species and reaches a maximum prevalence of 10.3%
in the 7–9 year age group. Average parasite densities in
infected persons are also strongly age dependent in both
cases and controls and peak at lower ages than the preva-
lence of infection (Table 1).
Age patterns of presumptive malaria episodes and 
attributable fractions
The incidence of presumptive malaria morbidity is high-
est in younger children, peaking in one year-old children
(Figure 2b). The latent class model provides estimates of
the proportions of these clinical attacks attributable to
each of the three malaria species, in each age group, and
parasite density class (Figure 1c to 1e).
Prevalence of infection and incidence of disease by age Figure 2
Prevalence of infection and incidence of disease by age. A: prevalence of infection in controls. B: Incidence of presump-
tive and attributable malaria cases.
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Figure 3a gives values of λ (k) for each of the Plasmodium
species, host age groups, and parasite density categories.
For each species, the youngest age group has the lowest
attributable fraction at any given density (Figure 3a). For
P. vivax and P. malariae, there is a very steep increase in the
attributable fraction with parasite density at around 800
parasites per μl for all age groups except the youngest,
with little age variation in the curve. Plasmodium falci-
parum shows a greater difference between age groups in
attributable fractions at a given level of parasitaemia, with
a general tendency (as previously reported [2]) for the
older age groups to have higher attributable fractions at
any given parasite density.
Operating characteristics of case definitions
The estimates of the sensitivity of diagnostic cut-offs by
age and parasite density show the inverse pattern to the
corresponding attributable fractions (Figure 4 and Addi-
tional file 1), indicating that a low cut-off is needed to
ensure high sensitivity in older individuals, while in
younger children, a higher cut-off can be used. The pat-
terns are broadly similar for all three species. A high spe-
cificity is achieved, even with very low cut-offs for all age
groups, and for all species, but particularly for P. malariae
in which the presence of any patent parasitaemia in a clin-
ical case has an estimated specificity of over 90% in all age
groups.
Age- and parasite density patterns of attributable disease
The estimates of incidence of attributable disease by age
and parasite density (Figure 3b) show very different pat-
terns to those for the attributable fractions. Plasmodium
falciparum does indeed show some age variations (as pre-
viously reported[2]), but these are most evident at rela-
tively low parasite densities. At the high parasite densities
found in most P. falciparum-attributable cases, there is lit-
tle difference between most of the age groups in incidence
of attributable disease (Figure 3b). Children in their first
year of life, however, stand out as having lower incidence
than other age-groups at relatively high parasite density
levels (≥ 800 parasites per μl).
P. vivax and P. malariae share a different pattern. After
adjustment for the time at risk in the different density cat-
egories, there seems to be almost no difference by age in
parasite density specific incidence of attributable disease
in the lower density classes (Figure 3b). At high parasite
densities in which the data for these species are sparse,
there is more variation between age groups in incidence.
In contrast to P. falciparum, there is a suggestion of a pla-
Table 1: Parasites densities in clinical cases and community controls
CASES CONTROLS
Median IQR Median IQR
P. falciparum
<1 9,480 [640, 39,800] 3000 [740, 14,800]
1 19,880 [4,640, >40,000] 1,200 [160, 5,360]
2–3 21,100 [5,600, >40,000] 1,600 [320, 6,550]
4–6 17,220 [3,520, >40,000] 680 [200, 2,560]
7–9 14,840 [2,440, >40,000] 480 [160, 1,680]
10–19 9,080 [1,100, 31,460] 240 [80, 720]
20+ 1,600 [320, 9,610] 160 [80, 440]
P. vivax
<1 4,480 [240, 15,260] 120 [70, 1,520]
1 5,540 [1,360, 12,870] 480 [130, 2,960]
2–3 4,500 [920, 12,820] 440 [120, 1,600]
4–6 2,440 [320, 9,120] 200 [120, 640]
7–9 1,280 [200, 7,480] 160 [80, 280]
10–19 300 [80, 3,380] 80 [40, 200]
20+ 120 [80, 280] 80 [40, 160]
P. malariae
<1 220 [90, 350] 80 [40, 740]
1 420 [120, 1,910] 200 [40, 360]
2–3 1380 [210, 3,360] 320 [120, 800]
4–6 1160 [450, 3,240] 320 [120, 680]
7–9 960 [280, 2,400] 160 [80, 360]
10–19 440 [120, 1760] 120 [60, 200]
20+ 120 [80, 480] 80 [40, 160]Malaria Journal 2009, 8:158 http://www.malariajournal.com/content/8/1/158
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teau in incidence as densities increase but this is based on
very little data, as high density infections with these spe-
cies are very unusual. The data for high density P. vivax
and P. malariae are rather sparse.
To translate the parasite density specific values into over-
all age- and species specific incidence of disease (Figure
2b), we sum both the estimated time at risk and the
number of attributable episodes across all parasite density
classes. P. vivax attributable morbidity peaks in 1 year-
olds, and P. falciparum morbidity peaks in 2–3 year olds
(Figure 2b). P. malariae attributable clinical disease is
restricted almost entirely to the 5–9 year age group, but
even in this age group the incidence of 0.031 episodes per-
person-year is small in comparison with that of acute ill-
ness attributable to the other species.
A simple empirical relationship between parasite density
and incidence of attributable disease seems to approxi-
mately hold across most age-groups and all three Plasmo-
dium species (ascending straight lines in Figure 3b):
where Iy is the incidence of disease episodes per person-
year experienced at parasite density y  parasites per μl
blood. This relationship lends itself to a simple formula
for estimating burden of disease from community-based
parasite density distributions:
where Itotal is the incidence per person-year, which can be
calculated separately for each Plasmodium  species. The
log ( ) log ( ) 10 0 1 10 Iy y =+ ββ (6)
Iy y d y total c
y
=
=
∞
∫ 10 0 1
0
β β θ () (7)
Attributable fractions and incidence of disease Figure 3
Attributable fractions and incidence of disease. A: attributable fractions by age, species and parasite density. B: incidence 
of attributable illness by age, species and parasite density. Dashed lines correspond to the regressions given in Table 2 with the 
line for P. falciparum corresponding to the analysis that excludes children < 1 year old.
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estimates of β0 and β1obtained for each species by a linear
regression through the datapoints in Figure 3 are remark-
ably similar to each other (Table 2).
Discussion
Previous studies of malaria tolerance by age have gener-
ally concentrated on the age patterns in the attributable
fractions (Figure 3a). By focusing on the diagnostic per-
formance of different cut-offs and the identification of
pyrogenic thresholds, such studies conclude that the age
distribution of the pyrogenic threshold is similar to that of
parasite densities, with high diagnostic cut-offs required
in young children, who thus appear more tolerant. How-
ever the diagnostic performance of these cutoffs depend
not only on pyrogenic thresholds, but also on age patterns
of non-malaria fevers. The present analyses allow for age-
variations in overall fever incidence in reporting incidence
of attributable disease and suggests different age-patterns
of tolerance.
Highly relevant to the mechanism of tolerance is the ques-
tion of whether it is specific for a given species of Plasmo-
dium, or whether it is common to all malaria species.
There may even be cross-tolerance with bacteria [9], since
malariatherapy studies found that Plasmodium infection
can reduce the response to bacterial endotoxins [28,29].
Prior to our study there was little epidemiological evi-
dence of whether tolerance to different Plasmodium spe-
cies follow similar dynamics. In the Punjab, the
relationship between morbidity and parasite densities was
found to be age-dependent in P. falciparum, but not so in
P. vivax [5]; however, unlike the situation in Papua New
Guinea, this was observed in an area of relatively low
malaria transmission where repeated infections with dif-
ferent malaria species are infrequent.
In Wosera, there are substantial differences between spe-
cies in the prevalence and density of infections and in clin-
ical incidence. P. falciparum is clearly the most important
cause of malaria morbidity (82.9%), followed by P. vivax
(15.1%), with P. malariae accounts for only 2.1% of attrib-
utable cases. However, across most densities and age
groups the incidence of disease at a given parasite density
is similar for all three species, and much of the variation
between the lines for different age groups in Figure 3b is
in the less frequent density classes (i.e. the low density
classes for P. falciparum, and the higher ones for P. vivax
and P. malariae), where sampling variation clearly plays a
role. For all three species, the lowest attributable fractions
at any given parasite density occur in the youngest age
group (Figure 3a), but tolerance is achieved with similar
age dynamics, even though infection with the different
Estimated operating characteristics of cutoffs Figure 4
Estimated operating characteristics of cutoffs. 
Receiver Operating Characteristic (ROC) curves of density 
cut-offs for the definition of P. falciparum and P. vivax clinical 
episodes. Shaded area: Sensitivity and Specificity > 80%. Den-
sity cutoffs: filled squares: 200/μl; open diamonds: 800/μl; 
filled circles: 3,200/μl; open squares 12,800/μl; filled dia-
monds: 40,000/μl.
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Table 2: Regression parameters for relationship of incidence of attributable disease with parasites density
Intercept β0,, [95% CI] Slope, β1, [95% CI]
P. falciparum (excluding < 1 year old) -4.29 [-4.62, -3.97] 1.33 [1.24, 1.42]
P. falciparum (all) -5.03 [-5.62, -4.43] 1.40 [1.23, 1.57]
P. vivax -5.51 [-6.07, -4.95] 1.57 [1.40, 1.73]
P. malariae -5.75 [-6.75, -4.75] 1.56 [1.26, 1.87]Malaria Journal 2009, 8:158 http://www.malariajournal.com/content/8/1/158
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species occurs at different rates, and the age patterns of
attributable morbidity are very different (Figures 3 and
2b).
The most important difference in age patterns of morbid-
ity is the relatively high incidence of P. vivax morbidity
compared with P. falciparum in the youngest age groups
(Figure 2b). This contrasts with the higher prevalence of P.
falciparum in the same age groups (Figure 2a) and with the
higher entomological inoculation rate of the latter para-
site[12]. This seems to mainly reflect better control of P.
falciparum densities in infants than of P. vivax densities,
and could reflect better protection for the former by
maternal antibodies [30] or/and active sensitization in
utero [31]. Pregnant women in the Wosera are more likely
to be infected with P. falciparum than with P. vivax [32],
which might lead to more acquired protection against
high density parasitaemia in the former case. However it
also appears to be the case that, at any given peripheral
parasite density, P. falciparum is less likely to cause disease
in infants than it would in older age groups.
Systematic variation in the ratio of circulating to seques-
tered parasites with age has previously been suggested as
explanation for patterns of age- and seasonal variation in
apparent tolerance of P. falciparum in infants[33]. An
important biologic difference between P. falciparum and
the other species is sequestration of late trophozoites in
the former, which means that the density of P. falciparum
in peripheral blood is an indirect and possibly imprecise
measure of the rate of pyrogen release at schizogony. Var-
iation in the ratio of circulating to sequestered parasites
presumably contributes imprecision to our analyses and
also lends itself as a possible explanation of why there
seems to be more age variation in levels of tolerance for P.
falciparum than for the other species (Figures 3), despite
the greater sample size.
The interpretation of such variations also needs to take
into consideration the logarithmic scales used on the axes
of Figure 3b, so small differences, notably the rather
higher incidence at given densities for P. vivax, are not very
obvious. Even if the mechanisms of tolerance are related,
equivalence cannot be assumed in the pyrogenic potential
of equal parasite counts of different species, with different
biochemistry. The absence of sequestration in P. vivax and
P. malariae means that the rate of schizogony relative to
the circulating density must be much lower than for P. fal-
ciparum, and the longer erythrocytic cycle of P. malariae
must also mean that it has an even lower rate of schizog-
ony relative to the circulating density.
Variation in age-incidence patterns may also arise because
of biases in the available data. Most obviously, not all epi-
sodes report to a health facility, so incidence estimates
need to be adjusted for imperfect access if they are to be
translated into disease burden. Age patterns in illness per-
ception and help-seeking could bias the clinical incidence
data, but there is no clear evidence that such biases are
important in Wosera. For instance the effect of distance
from health facility on help-seeking for febrile illnesses is
independent of age group [18]. The control surveys were
based on sampling from a complete demographic data-
base representative of the population and so do not repre-
sent a substantial source of bias.
Despite the effects of all these other factors, it appears that
age variation in clinical incidence mainly arises because of
differences in the ability to control parasitaemia, and both
age- and species-variation in tolerance are secondary phe-
nomena. Since tolerance may arise in tandem for the dif-
ferent parasite species, this suggests there may be cross-
species mechanisms of tolerance, and leads to a similar
empirical relationship between parasite density and inci-
dence of attributable disease for all species.
This potentially provides a practical approach for burden
of disease assessments in areas with high malaria ende-
micity, since it could provide a straightforward way of
using representative community-based data to avoid the
limitations of health management information systems.
There is a clear need to evaluate the generalizability of this
relationship to other settings, both to evaluate its practical
utility for estimating disease burden from survey data, and
for further understanding the biology of malaria toler-
ance.
Conclusion
In the Wosera area of Papua New Guinea, different
human malaria species show similar incidence of attribut-
able disease at the same parasite densities, compatible
with the hypotheses that there are pan-specific mecha-
nisms of tolerance. P. falciparum shows rather greater dif-
ferences in apparent tolerance between age groups than P.
vivax and P. malariae, which may in part reflect differences
in the ratio of circulating:sequestered parasites, rather
than in levels of tolerance. The implication that variations
in level of tolerance are of secondary importance in deter-
mining overall disease risk and the straightforward math-
ematical form that can be used to approximate the
relationship between parasite density and disease risk,
suggest that the latter might be useful for projecting dis-
ease burden from parasite density distributions assessed
in community-based parasitological surveys.
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